...
首页> 外文期刊>Multiple sclerosis: clinical and laboratory research >Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis.
【24h】

Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis.

机译:多发性硬化症患者接受米托蒽醌治疗后的药物诱发的Sweet's综合征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report a 55-year-old male patient with secondary progressive multiple sclerosis who developed an acute febrile syndrome with fever, neutrophilia and tender erythematous plaques and papules on his upper extremities after his fifth mitoxantrone infusion. Infectious, haematological and rheumatological diseases were ruled out, but skin biopsy showed neutrophilic infiltrations in the dermis consistent with Sweet's syndrome. Treatment with oral corticosteroids led to prompt improvement of systemic and cutaneous symptoms. To our knowledge, this is the first report of a patient with Sweet's syndrome after mitoxantrone therapy. Clinicians should be aware of Sweet's syndrome in patients with otherwise unexplained acute febrile illness and erythematous skin rash in association with mitoxantrone therapy. Skin biopsy helped to exclude other diseases and confirmed Sweet's syndrome.
机译:我们报告了一名55岁的男性继发性进行性多发性硬化症患者,他在接受第五次米托蒽醌输注后出现了发烧,嗜中性白血球和上肢红斑性斑块和丘疹的急性发热综合征。排除了传染病,血液病和风湿病,但皮肤活检显示真皮中嗜中性浸润与Sweet's综合征相符。口服皮质类固醇激素治疗可迅速改善全身和皮肤症状。据我们所知,这是米托蒽醌治疗后Sweet氏综合症患者的首次报道。对于患有无法解释的急性发热性疾病和米托蒽醌治疗伴有红斑性皮疹的患者,临床医生应注意Sweet综合征。皮肤活检有助于排除其他疾病,并证实了Sweet's综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号